HANSA BIOPHARMA AB NPV financial statements, including revenue, expenses, profit, and loss
The total revenue of 0RC7 for the last quarter is 55.98 M SEK, and it's 11.05% higher compared to the previous quarter. The net income of Q1 24 is -218.58 M SEK.